Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion

Eye

Volumn 22, Issue 9, 2008, Pages 1168-1171

  Gunduz K ^a   Bakri, S J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; EYE DISEASE; FEMALE; FOLLOW UP; HUMAN; LOW LEVEL LASER THERAPY; MALE; OPTICAL COHERENCE TOMOGRAPHY; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; STUDENT T TEST; VISUAL ACUITY;

EID: 48449090417     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6703040     Document Type: Article

References (13)

1. Rosenfeld PJ, Mosfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005; 36: 331-335.
2. Avery RL, Pieramici D, Rabena M, Castellarin AA, Nasir MA, Guist MJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006; 113: 363-372.
3. Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006; 113: 1695-1705.
4. Iturralde D, Spaide RF, Meyerle, CB, Klancnik JM, Yannuzzi LA, Fisher YL et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion. A short term study. Retina 2006; 26: 279-284.
5. Mason JO, Albert Jr MA, Vail R. Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema. Retina 2006; 26 356-357.
6. The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984; 98: 271-282.
7. Bakri SJ, Snyder MR, Reid JM, Pulido JS, Singh RJ. Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology 2007; 114 (5): 855-859.
8. Beer PM, Bakri SJ, Singh RJ, Lau W, Peters III GB, Miller M. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003; 110(4): 681-686.
9. Bakri SJ, Snyder MP, Reid JM, Pulido JS, Ezzat MK, Singh RJ. Pharmacokinetics of intravitreal ranibizumab (Lucentis). Ophthalmology 2007; 114: 2179-2182.
10. Çekiç O, Chang S, Tseng JJ, Bairle GR, Del Priore LV, Weisman H et al. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina 2005; 25: 851-858.
11. Chen SD, Sundaram V, Lochhead J, Patel CK. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2006; 141: 876-883.
12. Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 2007; 27: 419-425.
13. Pai SA, Shetty R, Vijayan PB, Venkatasubramaniam G, Yadav NY, Shetty BK et al. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol 2007; 143: 601-606.